Funded Healthcare Startups
Among the 9 most recent healthcare/biotechnology rounds shown, the largest disclosed amount is DefEYE’s $12M on 2025-10-29; that level is narrowly repeated…
Among the 9 most recent healthcare/biotechnology rounds shown, the largest disclosed amount is DefEYE’s $12M on 2025-10-29; that level is narrowly repeated, since Pluro Fertility and IVF ($14M, 2025-10-29) and WYTD Medical Technology ($14M, 2025-10-19) are the only disclosed rounds at $14M, while the rest of the disclosed figures sit at $8M (Cordance Medical, 2025-11-25), $5M (Ki Health, 2025-09-30), and $2M (Ascilion, 2025-09-24), with several entries undisclosed.
Dates cluster heavily in late October 2025: three of the nine rows close on 2025-10-29 (DefEYE $12M, Pluro Fertility and IVF $14M, and Increase Laboratorium Indonesia is 2025-11-04 instead), and a second tight window appears in November 2025 (2025-11-04 to 2025-11-27). Geography is dispersed across China, the United States, Singapore, Indonesia, India, and Sweden with no single city recurring by name. Stage labels are mixed: Seed appears 5 times (Cordance Medical 2025-11-25 is Seed; Bioactivx 2025-11-11 is Seed; Increase Laboratorium Indonesia 2025-11-04 is Seed but undisclosed; DefEYE 2025-10-29 is Seed; Ki Health 2025-09-30 is Seed), while Series A appears 2 times (Pluro Fertility and IVF on 2025-10-29 and WYTD Medical Technology on 2025-10-19), plus one Series B (Puguang Bio, 2025-11-27, undisclosed) and one Venture with an unknown Series (Ascilion, 2025-09-24, $2M). The rows span 2025-09-24 through 2025-11-27, and there are 2 undisclosed amounts (Puguang Bio on 2025-11-27; Increase Laboratorium Indonesia on 2025-11-04).
Most recent rounds
9 shownRelated listings
Frequently asked
What’s the largest disclosed round in this list, and how does it compare to the rest of the disclosed amounts?
The largest disclosed amount is $14M, held by Pluro Fertility and IVF (2025-10-29) and WYTD Medical Technology (2025-10-19). Below that top band, disclosed rounds drop to $12M (DefEYE on 2025-10-29), then $8M (Cordance Medical on 2025-11-25), $5M (Ki Health on 2025-09-30), and $2M (Ascilion on 2025-09-24).
Are there date clusters in the most recent entries, or is the timing spread out?
Timing clusters in late October 2025: DefEYE ($12M) and Pluro Fertility and IVF ($14M) both close on 2025-10-29, and WYTD Medical Technology closes shortly after on 2025-10-19. The page also concentrates activity in November 2025, ranging from Bioactivx’s 2025-11-11 to Puguang Bio’s 2025-11-27, with three additional November-dated Seed rounds (Cordance Medical 2025-11-25, Increase Laboratorium Indonesia 2025-11-04, and Bioactivx 2025-11-11).
Which stage labels dominate, and how are larger disclosed rounds distributed across stages?
Seed dominates the stage mix with 5 of 9 rows: Cordance Medical (Seed, 2025-11-25, $8M), Bioactivx (Seed, 2025-11-11, $1M), Increase Laboratorium Indonesia (Seed, 2025-11-04, undisclosed), DefEYE (Seed, 2025-10-29, $12M), and Ki Health (Seed, 2025-09-30, $5M). The largest disclosed amounts ($14M) occur in Series A rounds (Pluro Fertility and IVF on 2025-10-29 and WYTD Medical Technology on 2025-10-19).
Which geography appears most over-represented, and is there any recurring city among these entries?
No single city repeats: locations span Nanjing (Puguang Bio, 2025-11-27), Mountain View (Cordance Medical, 2025-11-25), Singapore (Bioactivx, 2025-11-11), Tangerang (Increase Laboratorium Indonesia, 2025-11-04), Sarasota (DefEYE, 2025-10-29), Mumbai (Pluro Fertility and IVF, 2025-10-29), Pingshan (WYTD Medical Technology, 2025-10-19), Saint Augustine (Ki Health, 2025-09-30), and Stockholm (Ascilion, 2025-09-24). Country coverage is spread across China, the United States, and multiple APAC markets rather than concentrating in one local hub.
Are there outliers in disclosed size, undisclosed reporting, or stage classification?
Yes. In disclosed amounts, Ascilion’s $2M on 2025-09-24 sits well below the mid-tier rounds ($5M Ki Health on 2025-09-30 and $8M Cordance Medical on 2025-11-25) and far under the $12M–$14M band (DefEYE 2025-10-29; Pluro Fertility and IVF 2025-10-29; WYTD Medical Technology 2025-10-19). In reporting, two entries are undisclosed (Puguang Bio on 2025-11-27 and Increase Laboratorium Indonesia on 2025-11-04), and one entry uses an unknown Series classification (Ascilion, Venture - Series Unknown, 2025-09-24, $2M).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.